Image Credit: Health and me
There's been an alarming increase of respiratory and gastrointestinal viruses in the United States lately, causing anxiety about a so-called "quad-demic". According to surveillance reports, influenza, COVID-19, RSV and norovirus are at very high levels everywhere. While the surge aligns with patterns typical for this season, several epidemiologists view simultaneous infections of such proportions to pose risks not only to individual healthcare but public health.
The incidence of the quad-demic should vary with seasonal patterns, vaccination rates, and public health interventions. Each virus alone is relatively easy to manage; however, the effect of all together could lead to overburdening of health care facilities and increase risks for those at higher risk. Continuing surveillance, early testing, and proactive prevention measures will play an important role in the control of these infections going forward.
While the term "quad-demic" sounds daunting, it must be taken into perspective. For years, we have had all these viruses together, and we have the capabilities to mitigate some of the risk. Vaccination, proper hygiene and using common sense helps individuals get through the season unscathed. Is the quad-demic a permanent fixture or just another seasonal wave? Let's break this down.
Typically, flu, COVID-19, and RSV have been the primary culprits behind seasonal respiratory infections. However, norovirus, a highly contagious stomach bug, has emerged as a fourth significant player, inducing fears of a more severe and widespread viral outbreak. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded nearly 500 norovirus outbreaks between August and December 2023, a substantial rise from the previous year’s numbers.
While the term "quad-demic" may sound ominous, the seriousness and consequences of such infections should be weighed in light of the U.S. healthcare system's experience with managing viral surges since the start of the COVID-19 pandemic.
Flu continues to be one of the most common and alarming seasonal illnesses. In the period spanning from 2023 to 2024, there were approximately 40 million cases of flu, and thousands of hospitalizations along with reported 47 deaths have been reported this season. Flu symptoms include fever, chills, cough, sore throat, muscle pain, and fatigue, with most recovering within a week or two but risky factors for severe illness effects occur in young children, elderly, and people with chronic conditions.
Despite its reduction from the first pandemic peak, COVID-19 is still rampant. The CDC estimates that alone between October and December 2023, there were between 2.7 and 5 million cases in the U.S. Hospitalization has increased by cities such as Los Angeles, Chicago, and New York. Symptoms are closely similar to the flu, fever, cough, and fatigue but uniquely presents in some cases as loss of taste and smell.
RSV is the most common cause of lower respiratory infections in infants, older adults, and immunocompromised individuals. While RSV peaked late in 2023 and early 2024, it continues to be a threat because it can lead to bronchiolitis and pneumonia. It is very similar to the common cold, presenting with symptoms such as congestion, runny nose, coughing, and fever, which can make it difficult to differentiate from flu or COVID-19 without testing.
Norovirus, also called the "stomach flu," is a highly contagious infection of the gastrointestinal tract, not a respiratory virus. It transmits quickly from contaminated food and water and contact with contaminated surfaces, causing such symptoms as diarrhea, vomiting, nausea, and stomach pain. Cases have shot up, the CDC said Monday, with reports of outbreaks surging compared with last year.
The greatest challenge during the quad-demic is how the four viruses are alike and thus make identification very hard with no testing applied. Most cases present symptoms common to all viruses: fever, tiredness, body pains, and respiratory, which includes coughing and congestions for influenza, COVID-19, and RSV; the other would be norovirus symptoms as nausea and vomiting can appear even in extreme influenza and COVID-19. This overlap increases the risk of misdiagnosis and delayed treatment, hence the need for early testing and proper medical guidance.
Also Read: Is US Preparing For A Quad- demic 2025?
The best defense against these viruses is a combination of vaccines, hygiene, and lifestyle precautions. While lifestyle modifications are highlighted as part of the constant need to eat healthy, ensure daily movement and drinking adequate amount of fluids. There is a sure short two preventive strategies that are effective:
While debates on masked wear continue on, experts on mask-wear affirm that this does not only have a historical precedent but works towards reducing airborne viruses spreading within the environments. Hospitals, though, ensure masking in key sections of themselves. Publicized mask-wear remains a discretion, though massing indoors still goes a longer way in cases like peak flu seasons.
If you notice the symptoms of these viruses, then it's best to be confined at home and avoid having face-to-face interaction with others and seek immediate attention from your physician if your condition worsens. Quarantining for some days can decrease the spread of infection.
As we move into the first half of 2025 and beyond, staying informed and proactive is the best strategy for maintaining health and avoiding unnecessary panic. The key takeaway? Stay vigilant, but don’t be alarmed—these viruses are here, but so are the means to fight them.
Credit: CDC
The Cyclospora outbreak that has spread across the US for more than three months has turned deadly, with Michigan—the hardest-hit state—reporting the country's first two deaths linked to the diarrhea-causing parasite.
According to the Michigan Department of Health and Human Services (MDHHS), both individuals had significant underlying health conditions.
"Two deaths have been identified as part of the cyclosporiasis outbreak affecting Michigan. According to medical records, both individuals had significant underlying health conditions that may have been impacted by cyclosporiasis and dehydration," the department said.
Health officials stressed that deaths from cyclosporiasis are rare, as the infection is generally not life-threatening. Michigan has reported 11,234 cases, including 193 hospitalizations.
The US Centers for Disease Control and Prevention (CDC) also confirmed the two outbreak-related deaths in Michigan. As of its July 28 update, the agency has recorded 6,707 laboratory-confirmed cases across 45 states since May 1, along with more than 11,500 suspected cases—primarily in Michigan and Ohio—that are yet to be laboratory confirmed. The outbreak has resulted in 423 hospitalizations.
The US Food and Drug Administration (FDA) has linked part of the outbreak to iceberg lettuce supplied by Taylor Farms de Mexico. The company voluntarily recalled affected products on July 17 and said it will no longer source iceberg lettuce from central Mexico for the rest of the growing season.
The recalled lettuce has been linked to illnesses in Indiana, Kentucky, Michigan, Ohio, and West Virginia. Separately, the CDC, FDA, and state health officials are investigating another Cyclospora outbreak linked to iceberg lettuce in nine states, which has sickened at least 1,947 people and hospitalized 98.
Officials are also investigating whether parsley and cilantro may be linked to the outbreak.
Cyclospora is a parasite that infects the intestines and is usually spread through contaminated food or water.
Most infections are mild and resolve without treatment. However, the illness can be prolonged or severe in people with weakened immune systems, who may require antibiotic treatment.
If you develop symptoms:
Doctors diagnose cyclosporiasis with a stool test that detects the Cyclospora parasite shed in stool.
Although some mild infections may resolve on their own, confirmed cases should be treated with antibiotics. The recommended treatment is the antibiotic trimethoprim/sulfamethoxazole (TMP-SMX).
Your doctor may also recommend:
Credit: AI
Tiny plastic particles may be making their way into one of the body's most protected organs, the brain, according to new research. This has raised concerns about the long-term health effects of microplastic exposure, particularly on brain health.
In a study published in Nature Medicine, researchers found that microplastics and nanoplastics were present in brain tissue, with significantly higher concentrations than in liver and kidneys.
One of the most important findings is that these particles can cross the blood-brain barrier, a protective shield that normally blocks harmful substances from entering the brain.
The researchers analysed brain tissue samples collected over several years and observed that they contained seven to 30 times more plastic particles than other organs.
They also found an increase in brain plastic concentrations in more recent samples, reflecting the growing burden of plastic pollution worldwide in the last few years.
"Our data suggest a trend of increasing concentrations of micro- and nanoplastics in the brain," the study authors wrote. They stressed that the findings do not prove these particles cause disease.
The researchers also reported higher concentrations of plastic particles in brain tissue from people diagnosed with dementia.
However, they cautioned that the study only identified an association and cannot determine whether microplastics contribute to dementia or whether brains diseased with dementia simply accumulate more particles.
Scientists are still trying to understand how these particles do harm once they reach the brain. Proposed theories include triggering inflammation, disrupting communication between nerve cells, or affecting blood flow, but none have yet been confirmed in humans.
Since nanoplastics are extremely small, researchers believe some may pass through the blood-brain barrier and become trapped in brain tissue.
The study found polyethylene, commonly used in food packaging and plastic bottles, was the most abundant type detected in the brain tissue.
Scientists emphasise that it is too early to conclude that microplastics directly damage the human brain.
"The findings are concerning, but they should not be interpreted as proof that microplastics cause neurological disease," the researchers emphasised. More studies are needed to determine whether the particles themselves are harmful or simply markers of environmental exposure.
Also read: Dementia Progression Observed To Slow Down When You Do This Exercise 3 Times A Week
While eliminating exposure entirely is nearly impossible, experts recommend practical steps that may lower intake:
The study adds to mounting evidence that microplastics are no longer just an environmental issue. They are increasingly being detected throughout the human body, including the blood, lungs, placenta and now the brain.
Credit: AI
A new study by the US Centers for Disease Control and Prevention (CDC) has found that nearly one in three patients who were hospitalised were diagnosed with invasive mould disease (IMD) died during their hospital stay.
The findings highlighted the urgent need for better surveillance, hygiene, early diagnosis, and greater awareness among healthcare professionals.
The findings come from the surveillance study of invasive mould infections conducted by the CDC across four hospitals in Atlanta and Georgia, between 2020 and 2024.
Researchers identified 499 confirmed cases of invasive mould disease during the five-year study period. Around 33% of these patients died while hospitalised, while the overall 90-day mortality rate reached 45%.
Nearly half of the patients needed intensive care, and about 50% needed ventilation, highlighting just how severe these infections can turn.
Patients who had a recent or current COVID-19 infection were found to be even worse. Their 90-day mortality rate was 66%, compared with 41% among patients without COVID-19.
"Our findings demonstrate that invasive mold disease is associated with substantial illness and death," the CDC researchers wrote, adding that active surveillance can help improve understanding of how common these infections are and guide prevention efforts.
Also read: DR Congo Ebola Outbreak Becomes World’s Second Largest As Death Toll Surpasses 1,500
Unlike the mould that grows on damp walls or spoiled food, invasive mould disease occurs when fungal spores enter the body through the lungs, wounds, or contaminated medical equipment and spread into deep tissues, blood vessels, or organs.
The infections are most commonly caused by fungi such as Aspergillus, Mucorales, Fusarium, and Scedosporium. Once inside the body, they can rapidly become life-threatening if not diagnosed and treated early.
Also read: Vibrio Vulnificus: US Records First Flesh-eating Bacteria Death Of 2026
The disease rarely affects healthy individuals. Instead, it primarily targets people whose immune systems are already weakened, including:
Also read: Donald Trump Urges RFK Jr. To Accelerate Childhood Vaccine Rollback
One of the biggest challenges is that invasive mould disease is not a nationally reportable disease in the United States, meaning health authorities do not routinely collect nationwide data on cases. Researchers believe the actual burden may therefore be underestimated.
The CDC authors noted that active surveillance is essential to estimate disease incidence, identify outbreaks, and improve patient outcomes. They also highlighted that patients with COVID-19 experienced significantly more severe disease, suggesting clinicians should remain vigilant for fungal complications in critically ill patients.
Outside experts have also warned that factors such as climate change, extreme weather events, an ageing population, and rising antifungal drug resistance could contribute to an increase in serious fungal infections in the coming years.
Although invasive mould infections remain relatively uncommon, the study shows they carry an alarmingly high risk of severe illness and death among vulnerable patients. Researchers say increasing awareness, recognising symptoms early, improving hospital surveillance, and developing faster diagnostic tools could help identify infections sooner and improve survival.
© 2024 Bennett, Coleman & Company Limited